🔓
Sign in as a Member to unlock the full view of S.2336. · Full carveout list, all affected companies, party defectors, and 30-day trade predictions.
Become a Member$29.99/mo already a Member? Sign in →
S.2336 · 119TH CONGRESS

Halting the Epidemic of Addiction and Loss Act of 2025

Status
In Committee
Latest Action
2025-07-17
Sponsor
Cornyn, John (R-Texas)
Official Source
Investability
0/100
Stage
COMMITTEE
Related Bills
1
Full Text
2,441 chars
Alive
Yes

What This Bill Does · Plain English

Summary · Congress.gov
Halting the Epidemic of Addiction and Loss Act of 2025 This bill requires that, when the Department of Health and Human Services (HHS) issues new regulations or guidance on grant programs addressing opioid use disorders, references to an opioid overdose reversal drug (e.g., naloxone) must broadly include any opioid overdose reversal drug approved by the Food and Drug Administration. Within one year after the bill’s enactment, HHS must update all references accordingly in regulations or guidance issued prior to the bill’s enactment that are applicable to State Opioid Response Grants, Tribal Opioid Response Grants, or certain other grants relating to substance use disorder prevention.

Action Timeline

2025-07-17
Introduced in Senate
2025-07-17
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Frequently Asked Questions

Did S.2336 pass?
S.2336 is still alive. Current stage: COMMITTEE. Pass likelihood: pending.
What does S.2336 do?
Halting the Epidemic of Addiction and Loss Act of 2025 This bill requires that, when the Department of Health and Human Services (HHS) issues new regulations or guidance on grant programs addressing opioid use disorders, references to an opioid overdose reversal drug (e.g., naloxone) must broadly include any opioid overdose reversal drug approved by the Food and Drug Administration. Within one year after the bill’s enactment, HHS must update all references accordingly in regulations or guidance issued prior to the bill’s enactment that are applicable to State Opioid Response Grants, Tribal Opi…
Who sponsored S.2336?
S.2336 was sponsored by John Cornyn (R-Texas).

Full Bill Text

119 S2336 IS: Halting the Epidemic of Addiction and Loss Act of 2025 U.S. Senate 2025-07-17 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. II 119th CONGRESS 1st Session S. 2336 IN THE SENATE OF THE UNITED STATES July 17, 2025 Mr. Cornyn (for himself and Ms. Hassan ) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To ensure references to opioid overdose reversal agents in certain grant programs of the Department of Health and Human Services are not limited to naloxone. 1. Short title This Act may be cited as the Halting the Epidemic of Addiction and Loss Act of 2025 . 2. References to opioid overdose reversal agents in HHS grant programs (a) In general The Secretary of Health and Human Services shall ensure that, as appropriate, whenever the Department of Health and Human Services issues a regulation or guidance for any grant program addressing opioid misuse and use disorders, any reference to an opioid overdose reversal drug (such as a reference to naloxone) is inclusive of any opioid overdose reversal drug that has been approved under section 505 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 ) for emergency treatment of a known or suspected opioid overdose. (b) Existing references (1) Update Not later than one year after the date of enactment of this Act, the Secretary of Health and Human Services shall update all references described in paragraph (2) to be inclusive of any opioid overdose reversal drug that has been approved or otherwise authorized for use by the Food and Drug Administration. (2) References A reference described in this paragraph is any reference to an opioid overdose reversal drug (such as naloxone) in any regulation or guidance of the Department of Health and Human Services that— (A) was issued before the date of enactment of this Act; and (B) is included in— (i) the grant program for State and Tribal response to opioid use disorders under section 1003 of the 21st Century Cures Act ( 42 U.S.C. 290ee–3a ) (commonly referred to as State Opioid Response Grants and Tribal Opioid Response Grants ); or (ii) the grant program for priority substance use disorder prevention needs of regional and national significance under section 516 of the Public Health Service Act ( 42 U.S.C. 290bb–22 ).
🔒 GovGreed Pro · Trading Intelligence on S.2336 Get Access — $29.99/mo
Loading intelligence layer…
Bill text sourced from GovInfo.gov · public domain · last updated 2026-11-17. Plain-English summary, score breakdown, and trading-intelligence panels are GovGreed-original analysis derived from STOCK Act filings, SEC Form 4 disclosures, FEC contributions, and Senate LDA lobbying reports — all publicly filed federal records. GovGreed is not affiliated with the U.S. Government. Not financial advice. [live render]